ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,358Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 324

$750K Total Retail Price of All Prescriptions

Rank: 37 out of 324

454 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 454 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 11,805 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 562 475 1 2
SIMVASTATIN 472 426 2 1
FUROSEMIDE 433 398 3 7
HYDROCODONE-ACETAMINOPHEN 428 292 S3 4 5
OMEPRAZOLE 421 335 5 6
AMLODIPINE BESYLATE 417 372 6 4
ATORVASTATIN CALCIUM 390 363 7 12
LISINOPRIL 377 311 8 3
HYDROCHLOROTHIAZIDE 296 271 9 11
METFORMIN HCL 284 238 10 9
POTASSIUM CHLORIDE 278 248 11 8
WARFARIN SODIUM 272 263 12 10
GABAPENTIN 253 188 13 13
METOPROLOL TARTRATE 236 215 14 14
ATENOLOL 229 202 15 18
ZOLPIDEM TARTRATE 188 134 16 20
LOSARTAN POTASSIUM 160 152 17 15
CITALOPRAM HBR 153 120 18 16
TRAMADOL HCL 150 78 19 19
CLOPIDOGREL 147 122 20 38
DOXAZOSIN MESYLATE 144 128 21 76
GLIMEPIRIDE 139 114 22 37
ALLOPURINOL 138 129 23 27
PRAVASTATIN SODIUM 134 107 24 21
METOPROLOL SUCCINATE 129 111 25 17
TAMSULOSIN HCL 120 118 26 26
PANTOPRAZOLE SODIUM 116 110 27 34
NAMENDA 113 113 28 31
BENAZEPRIL HCL 111 111 29 75
FLUTICASONE PROPIONATE 103 93 30 32
CARBIDOPA-LEVODOPA 102 102 31 80
VESICARE 101 101 32 166
LANTUS 99 53 33 39
CRESTOR 97 95 34 28
SINGULAIR 95 76 35 92
PREDNISONE 93 77 36 36
PLAVIX 90 72 37 63
PHENYTOIN SODIUM EXTENDED 87 39 38 128
MIRTAZAPINE 84 84 39 41
CYMBALTA 84 39 39 45
NEXIUM 81 62 41 33
CARVEDILOL 79 77 42 22
PROPRANOLOL HCL 78 78 43 95
CELEBREX 77 72 44 96
SERTRALINE HCL 73 55 45 23
DIOVAN 72 49 46 56
HYDROMORPHONE HCL 71 14 S2 47 193
ALENDRONATE SODIUM 70 57 48 24
AMITRIPTYLINE HCL 69 29 R 49 66
DIGOXIN 67 62 50 40
SYNTHROID 66 56 51 30
METOLAZONE 64 64 52 147
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 40 52 35
VERAPAMIL ER 62 58 54 127
MONTELUKAST SODIUM 59 43 55 143
ADVAIR DISKUS 59 50 55 61
POLYETHYLENE GLYCOL 3350 59 41 55 49
PRAMIPEXOLE DIHYDROCHLORIDE 54 41 58 159
METHADONE HCL 54 0 S2 58 142
QUETIAPINE FUMARATE 54 52 58 69
BUMETANIDE 52 49 61 82
METFORMIN HCL ER 51 46 62 74
BENICAR 51 47 62 160
VENLAFAXINE HCL ER 51 32 62 86
NOVOLOG 51 28 62 60
PROAIR HFA 50 41 66 50
LOSARTAN-HYDROCHLOROTHIAZIDE 50 50 66 44
FINASTERIDE 50 50 66 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.